Research progress of quercetin on anti-anxiety and anti-depression
Authors:
Open Access
- 30 May 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 16, 1621510
Abstract
Anxiety and depression represent two of the most prevalent mental disorders worldwide, with current pharmacotherapies often limited by adverse effects and treatment resistance. Consequently, research into natural products for mental health interventions has attracted growing scientific interest. Quercetin, a bioactive flavonoid ubiquitously present in plant-derived flowers, fruits, and dietary sources, exhibits diverse pharmacological properties, including antioxidant, anxiolytic, and antidepressant activities. This review systematically summarizes the fundamental characteristics of quercetin, focusing on its core molecular mechanisms in alleviating anxiety- and depression-like behaviors, preclinical evidence from experimental models, and the current landscape of clinical investigations. By critically analyzing its therapeutic advantages, translational challenges, and emerging research priorities, this synthesis aims to offer a theoretical foundation for the development of quercetin-based formulations and their clinical implementation in mood disorder management.Keywords
This publication has 49 references indexed in Scilit:
- Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease managementAgeing Research Reviews, 2025
- Depression and anxiety in multiple sclerosis. Review of a fatal combinationJournal of Neural Transmission, 2024
- Quercetin’s Restorative Properties in Male Mice with 3-Nitropropionic Acid-induced Huntington-like Symptoms: Molecular Docking, Behavioral, and Biochemical AssessmentCell Biochemistry and Biophysics, 2024
- Propofol Alleviates Anxiety‐Like Behaviors Associated with Pain by Inhibiting the Hyperactivity of PVNCRH Neurons via GABAA Receptor β3 SubunitsAdvanced Science, 2024
- Quercetin alleviates chronic unpredictable mild stress-induced depressive-like behaviors by promoting adult hippocampal neurogenesis via FoxG1/CREB/ BDNF signaling pathwayBehavioural Brain Research, 2021
- Depression and Anxiety Reduce the Probability of Achieving a State of Sustained Minimal Disease Activity in Patients With Psoriatic ArthritisArthritis Care & Research, 2021
- Dietary quercetin attenuates depressive-like behaviors by inhibiting astrocyte reactivation in response to stressBiochemical and Biophysical Research Communications, 2020
- Role of oxidative stress in depressionDrug Discovery Today, 2020
- Association Between Antidepressant Drug Use and Hip Fracture in Older People Before and After Treatment InitiationJAMA Psychiatry, 2019
- Estrogen receptor signaling mechanisms2019